BC
Boxer Capital Portfolio holdings
AUM
$2.04B
1-Year Return
108.35%
This Quarter Return
+26.74%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.78B
AUM Growth
+$199M
(+13%)
Cap. Flow
-$23.2M
Cap. Flow
% of AUM
-1.3%
Top 10 Holdings %
Top 10 Hldgs %
47.19%
Holding
82
New
6
Increased
3
Reduced
8
Closed
9
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$38.4M |
| 2 |
Ventyx Biosciences
VTYX
|
$29.7M |
| 3 |
Veru
VERU
|
$28.8M |
| 4 |
Exelixis
EXEL
|
$19.6M |
| 5 |
Gossamer Bio
GOSS
|
$13.3M |
Top Sells
| 1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$42.9M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$37.1M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$15.3M |
| 4 |
Biomea Fusion
BMEA
|
$14.2M |
| 5 |
Milestone Pharmaceuticals
MIST
|
$14.2M |
Sector Composition
| 1 | Healthcare | 99.33% |
| 2 | Financials | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELEV
76
DELISTED
Elevation Oncology
ELEV
| – | – |
-872,780
| Closed | -$1.22M |
|
77
ESSA Pharma
EPIX
$11M
| – | – |
-724,500
| Closed | -$2.28M |
|
78
GH Research
GHRS
$859M
| – | – |
-1,013,399
| Closed | -$10.1M |
|
79
Nuvation Bio
NUVB
$1.13B
| – | – |
-4,341,009
| Closed | -$14.1M |
|
80
Solid Biosciences
SLDB
$425M
| – | – |
-355,735
| Closed | -$3.29M |
|
|
81
SPDR S&P Biotech ETF
XBI
$5.24B
| – | – |
-500,000
| Closed | -$37.1M |
|
|
TPTX
82
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – |
-570,745
| Closed | -$42.9M |
|